Transaction in Own Shares and TVR

Summary by AI BETAClose X

North Atlantic Smaller Companies Investment Trust PLC announced on September 19, 2025, the purchase of 125,000 of its own ordinary shares, with a nominal value of 0.5 pence each, for cancellation. The purchase price was 375.245 pence per share, with settlement scheduled for September 23, 2025. Following the cancellation, the company's issued share capital will consist of 131,325,000 ordinary shares with voting rights as of September 23, 2025. Shareholders can use this figure of 131,325,000 ordinary shares as the denominator to determine if they need to disclose their interest in the company under FCA rules.

Disclaimer*

North Atlantic Smlr Co Inv Tst PLC
22 September 2025
 

 

https://dw6uz0omxro53.cloudfront.net/2841141/5920af03-1338-4a2f-b876-727a5c8e76e8.gif

North Atlantic Smaller Companies Investment Trust PLC

("NASCIT")

 

Transaction in Own Shares and TVR

  

The Company announces that on the 19 September 2025, it purchased 125,000 Ordinary Shares with a nominal value of 0.5 pence each for cancellation at a price of 375.245 pence per share. The settlement date is 23 September 2025.

Following the above purchases and subsequent cancellation of the shares, the Company's issued share capital as at 23 September 2025 will consist of 131,325,000 Ordinary shares with voting rights.

The above figure of 131,325,000 Ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interests in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Ben Harber, Company Secretary

benh@woodhamcorpservices.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings